Results for ipomagnesemija translation from Maltese to English

anoreksja ipergliċemija ipokalċemija ipokalemija ipomagnesemija ipofosfatemija
anorexia hyperglycaemia hypocalcaemia hypokalaemia hypomagnesaemia hypophosphatemia

ipogliċemija, iperuriċemija, żieda fl- aptit minħabba nuqqas tal- vitamina b12, ipomagnesemija, ipofosfatemija.
uncommon: hyperkalaemia, cachexia, hypercalcaemia, hypocalcaemia, hypernatraemia, hyponatraemia, hypoglycaemia, hyperuricaemia, vitamin b12 deficiency, appetite increased, hypomagnesaemia, hypophosphataemia.

aċidosi, iperkalemija, ipokalemija, ipergliċemija, ipomagnesemija, ipokalċemija, iperkolesterolemija, iperlipidemija, ipofosfatemija, iperurikemija, gotta, anoreksja
hyperlipidaemia, hypophosphataemia, hyperuricaemia, gout, anorexia

pazjenti li qed jingħataw, jew li diġà ngħataw, prodotti mediċinali magħrufa li jikkawżaw ipokalemija jew ipomagnesemija, bħal ngħidu aħna djuretiċi jew amphotericin b, għandhom mnejn ikollhom riskju ogħla ta’ torsade de pointes.
patients who are receiving, or who have received, medicinal products known to cause hypokalemia or hypomagnesaemia, such as diuretics or amphotericin b, may be at higher risk for torsade de pointes.

ir-riskju tat-torsade de pointes hu marbut ma’ kemm tkun il-prolongazzjoni qt, l-għoti konkomitanti tal-prodotti mediċinali li jipprolungaw il-qt (bħal ngħidu aħna antjarrimiċi tal-klassi ia u iii (eż. quinidine, amiodarone, sotalol, dofetilide), antipsikotiċi (eż. thioridazine), antidipressanti (eż. amitriptyline), xi macrolides (eż. erythromycin), xi antistamini (eż. terfenadine u astemizole), xi antibijotiċi quinolone (eż. sparfloxacin), u mediċini individwali oħra li huma magħrufa li jżidu l-intervall qt (eż. cisapride), passat ta’ torsade de pointes, prolongazzjoni pre-eżistenti ta’ l-intervall qt, insuffiċjenza tal-qalb konġestiva, l-għoti ta’ djuretiċi li jnaqqsu l-potassju, amphotericin b jew kondizzjonijiet oħra li jikkaġunaw ipokalimja jew ipomagnesemija.
the risk of torsade de pointes is related to the extent of qt prolongation, concomitant administration of qt prolonging medicinal products (such as class ia and iii antiarrythmics (e.g. quinidine, amiodarone, sotalol, dofetilide), antipsychotics (e.g. thioridazine), antidepressants (e.g. amitriptyline), some macrolides (e.g. erythromycin), some antihistamines (e.g. terfenadine and astemizole), some quinolone antibiotics (e.g. sparfloxacin), and other individual drugs known to increase qt interval (e.g. cisapride)), a history of torsade de pointes, pre-existing qt interval prolongation, congestive heart failure, administration of potassium-wasting diuretics, amphotericin b or other conditions that result in hypokalemia or hypomagnesaemia.